Absorb Bioresorbable Vascular Scaffold

DEVICE3 trials

Sponsors

Abbott Medical Devices, The University of New South Wales, Ottawa Heart Institute Research Corporation

Conditions

Arterial Occlusive DiseasesChronic Total Occlusion of Coronary ArteryCoronary Artery DiseaseCoronary Artery RestenosisCoronary Artery StenosisCoronary DiseaseCoronary OcclusionCoronary Restenosis

Unknown Phase

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

CompletedNCT01759290

Abbott Medical DevicesChronic Total Occlusion of Coronary Artery, Coronary Artery Disease, Coronary Artery Restenosis +4

Start: 2013-01-31End: 2015-12-31Updated: 2016-10-19

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

TerminatedNCT02793349

The University of New South WalesArterial Occlusive Diseases, Ischemia, Peripheral Arterial Disease (PTA

Start: 2015-06-30End: 2017-06-30Updated: 2019-04-17

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

WithdrawnNCT03236415

Ottawa Heart Institute Research CorporationCoronary Artery Disease, Diabetes Mellitus

Start: 2017-08-31End: 2019-07-31Updated: 2017-10-19